openPR Logo
Press release

Coagulation factor concentrate Market Size, Share, Impressive Industry Growth, Report 2027

10-05-2021 07:33 AM CET | Health & Medicine

Press release from: Orion Market Research

The Global Coagulation factor concentrate market is estimated to grow at a significant CAGR during the forecast period. Hemophilia is best treated by replacing the missing blood clotting factor, which allows the blood to clot properly. This is typically done by injecting clotting factor concentrates, which are therapeutic products, into a person's vein. Doctors typically prescribe treatment agents for either episodic or prophylactic care. Prophylactic care is used to prevent bleeding episodes from arising. Episodic treatment is used to stop a patient's bleeding episodes. By transforming severe haemophilia (factor VIII or IX less than 1%) into a clinically milder version of the disease, clotting factor concentrate prophylaxis aims to preserve joint function. The single most important predictor of cost in haemophilia treatment is the use of clotting factor concentrates.

A full report of Coagulation factor concentrate Market is available at:

The demand for recombinant and plasma-derived factor VIII and factor IX, which are used to treat haemophilia, is increasing due to an increase in the number of hemophilic patients around the globe. In addition, the market is expected to expand as the rate of haemophilia diagnosis rises and the usage of prophylactic treatment for haemophilia increases. However, the high cost of recombinant products, serious side effects associated with plasma-derived therapies, and strict regulatory regulations are all stifling the global haemophilia market's growth. The increasing the prevalence of haempophilia snd prophylactic treatment for haemophila increases will drive the coagulation factor concentrate market.

To learn more about this report request a sample copy @

According to Centre for disease control prevention (CDC) in the United States, around 70% of people with haemophilia get multidisciplinary, comprehensive care through a network of federally sponsored haemophilia treatment facilities. Hemophilia A affects one out of every 5,000 male babies born. Every year, about 400 infants are born with haemophilia A. People who got care at haemophilia treatment facilities had 40% reduced mortality and hospitalisation rates for bleeding problems.

Market Coverage

• The market number available for – 2020-2026
• Base year- 2020
• Forecast period- 2021-2026
• Segment covered
o By Type
o BY Application
• Region covered
o North America
o Europe
o Asia-Pacific
o Rest of the world
• Competitive Landscape- Medscape., CSL Behring, Octapharma.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Market Segmentation

By Type

• Coagulation Factor IX
• Coagulation Factor XIII
• Others
By Application
• Hospitals and Clinics
• Research Laboratories
• Academic Institutions

For more customized data, request for report customization @

Coagulation factor concentrate Market– Segment by Region

North America

• United States
• Canada


• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe


• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Medscape.
• CSL Behring
• Octapharma

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Coagulation factor concentrate Market Size, Share, Impressive Industry Growth, Report 2027 here

News-ID: 2416798 • Views: 194

More Releases from Orion Market Research

Vehicle Reseller Market 2021 Size, Growth Analysis Report, Forecast to 2027
The global vehicle reseller market is anticipated to grow at a considerable CAGR of 8.0% during the forecast period (2021-2027). The rise in competition among the market and the threat of new entries are the factors will bolster the growth of the vehicle reselling dealership business. The reliable & add on service and quality has changed the perspective of consumers toward the used vehicle business. In addition, franchised dealers along
Metamaterial Technology Market Size | COVID-19 Impact Analysis | Forecast to 202 …
The global metamaterial technology market is anticipated to grow at a significant CAGR of around 3022.5% during the forecast period. The rising investment in defence sector by the major economies is the prominent factor accelerating the market growth. For instance, according to the Peterson Foundation report 2021, in the US, in 2020, defense spending accounts $778 billion or more than 10% of all federal spending and nearly half of the
Global Triamcinolone Ointment Chlorofluorocarbons Market Trends 2021 | Segmentat …
The global triamcinolone ointment chlorofluorocarbons market is expected to grow at a significant CAGR during the forecast period (2021-2027). Skin disease affects millions of people across the globe and is one of the primary causes of the rising global disease burden. Triamcinolone is a drug that is used to treat inflammation in a variety of diseases such as allergic responses, eczema, and psoriasis. A variety of skin diseases are caused
Global Sleep Disorder Treatment Drugs Market Size, Share, Analysis, Industry Rep …
The global sleep disorder treatment drugs market is expected to grow at a significant CAGR during the forecast period (2021-2027). Sleep disorders are becoming more common across the globe, rising stress levels, a growing geriatric population, and increased awareness about various treatment choices for this disease are all likely to drive the market growth. According to the Narcolepsy Network, nearly one out of every 2,000 persons in the US

All 5 Releases

More Releases for Coagulation

Global Blood coagulation analyzer Market, Blood coagulation analyzer Market 2020 …
The Blood coagulation analyzer market report provides a comprehensive view of global Blood coagulation analyzer industry. The study provides the industry overview with its growth analysis including CAGR, market shares, sales, gross margin, value, future trends, market opportunities etc. The study also includes analysis of historic data from 2015 to 2019 along with forecast from 2020 to 2025. Further, the Blood coagulation analyzer report contains drivers andrestraints of Blood coagulation
Global Coagulation Factors Market Research Report
This report studies the global Coagulation Factors market status and forecast, categorizes the global Coagulation Factors market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Shire (Baxter) Bayer CSL Pfizer Grifols Biogen Octapharma NovoNordisk Greencross Kedrion BPL Hualan Bio RAAS Geographically, this
Coagulation Factor IX Market Competitive Insight and Key Drivers 2018 to 2026(Co …
Deficiency of coagulation factor IX will result in Hemophilia B disorder. Treatment of Hemophilia B has been evolved with the introduction of first of plasma-derived and then of recombinant FIX concentrates. Prevalence of Hemophilia B is anticipated to be 1 in 30,000 individuals across the globe, which is likely to bolster significant demand for coagulation factor IX over foreseeable future. Incidences of hemophilia B have not been well known however,
01-30-2019 | Health & Medicine
Global Coagulation Factor IX Market Projections Highlighting Primary Trends unti …
Coagulation factor IX isn’t made by the body of hemophilia B patient thereby, external injection of coagulation factor IX is necessary for the treatment of such disorder. Coagulation factor IX is always injected directly into a vein. Lack of treatment options for hemophilia B disorder have further increased adoption of coagulation factor IX. This has brought number of opportunities for new entrants to enter in Coagulation Factor IX Market.  Request Brochure
Global Coagulation Analysers Market: Regulatory Challenges May Restrain the Mark …
Market Research Report Search Engine (MRRSE) recently announced the addition of a new research study to its comprehensive collection of research reports. The research report, titled “Coagulation Analysers Market: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)” offers a detailed analysis of the market, providing insights into the market dynamics that are expected to influence the overall market positively in the next few years. Furthermore, the
Global Blood Coagulation Analyzer Market 2017, Global Blood Coagulation Analyzer …
Global Blood Coagulation Analyzer Market 2017, presents a professional and in-depth study on the current state of the Blood Coagulation Analyzer market globally, providing basic overview of Blood Coagulation Analyzer market including definitions, classifications, applications and industry chain structure, Blood Coagulation Analyzer Market report provides development policies and plans are discussed as well as manufacturing processes and cost structures. Blood Coagulation Analyzer market size, share and end users are analyzed